Abstract

Sepsis is of major importance worldwide, placing economic burden on healthcare systems and often resulting in morbidity and mortality in affected patients. The use of rapid, effective prognostic laboratory tests will no doubt improve decision-making on the part of the physician. We describe prospective observational studies of two commonly used biomarkers when monitoring the clinical course of sepsis, procalcitonin and C-reactive protein, herein.

Key words: Procalcitonin, C-reactive protein, sepsis.